Literature DB >> 1968123

Tuberculosis and human immunodeficiency virus infection in developing countries.

A D Harries1.   

Abstract

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Demographic Factors; Developing Countries; Diseases; Hiv Infections; Infections; Literature Review; Measurement; Mortality; Population; Population Dynamics; Prevalence; Research Methodology; Signs And Symptoms; Treatment; Tuberculosis; Viral Diseases

Mesh：

Substances：

Year:  1990        PMID： 1968123     DOI： 10.1016/0140-6736(90)90216-r

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  58 in total

1.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

2.  The management of tuberculous meningitis.

Authors:  M Humphries
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

3.  A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.

Authors:  D Guwatudde; S M Debanne; M Diaz; C King; C C Whalen
Journal:  Prev Med       Date:  2004-11       Impact factor: 4.018

4.  HIV infection in women.

Authors:  S Norman; J Studd; M Johnson
Journal:  BMJ       Date:  1990-12-01

5.  Yaws, an endemic treponematosis reconsidered in the HIV era.

Authors:  G T Noordhoek; J D van Embden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

6.  Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.

Authors:  C Chintu; C Luo; G Bhat; M Raviglione; H DuPont; A Zumla
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

7.  Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.

Authors:  Geetha Ramachandran; A K Hemanth Kumar; P K Bhavani; T Kannan; S Ramesh Kumar; N Poorana Gangadevi; V V Banurekha; L Sekar; N Ravichandran; G Mathevan; G N Sanjeeva; Rajeshwar Dayal; Soumya Swaminathan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

8.  Shortfalls identified in the management of tuberculosis for Mozambican patients obtaining health care services in Malawi.

Authors:  Adamson S Muula; Yohane Nyasulu; Henry Feluzi; Collins Magalasi
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

9.  DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania.

Authors:  Z H Yang; I Mtoni; M Chonde; M Mwasekaga; K Fuursted; D S Askgård; J Bennedsen; P E de Haas; D van Soolingen; J D van Embden
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast.

Authors:  K M De Cock; E Gnaore; G Adjorlolo; M M Braun; M F Lafontaine; G Yesso; G Bretton; I M Coulibaly; G M Gershy-Damet; R Bretton
Journal:  BMJ       Date:  1991-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.